These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 278147)

  • 1. Studies on the pharmacokinetics of cefoxitin, cefuroxime, cephaloridine and cephalothin using subcutaneous tissue cages.
    Rylander M; Holm SE; Norrby R; Brorson JE
    Scand J Infect Dis Suppl; 1978; (13):52-7. PubMed ID: 278147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.
    Sonneville PF; Kartodirdjo RR; Skeggs H; Till AE; Martin CM
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):397-403. PubMed ID: 971703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of biliary excretion of cefazolin and other cephalosporins with reference to the relationship between serum levels and administration conditions.
    Nishida M; Murakawa T; Matsubara T; Kohno Y; Yokota Y
    Chemotherapy; 1976; 22(1):30-6. PubMed ID: 1253628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacodynamics of cephaloridine and cephalothin combined with sulfalene in rabbits].
    Bobrov VI; Beletskaia GT; Iakovlev VP
    Antibiotiki; 1984 Nov; 29(11):823-5. PubMed ID: 6524880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implanted tissue-cages: a critical evaluation of their relevance in measuring tissue concentrations of antibiotics.
    Ryan DM
    Scand J Infect Dis Suppl; 1978; (13):58-62. PubMed ID: 278148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the pharmacokinetics of cephalosporin antibiotics.
    Andersson KE
    Scand J Infect Dis Suppl; 1978; (13):37-46. PubMed ID: 278145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Penetration of cephaloridine and cephalothin into the cerebrospinal fluid-clinical study (author's transl)].
    Kano M; Ohta H; Kinjo T; Ito A
    No Shinkei Geka; 1975 Apr; 3(4):305-12. PubMed ID: 1239674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of cephalothin and ceftriaxone into experimental interstitial tissue fluid in rabbits.
    Gonzalez Molinello A; Alonso Gonzalez AC; Mariño EL; Dominguez-Gil A
    Arzneimittelforschung; 1986 Jul; 36(7):1082-5. PubMed ID: 3768077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on chemotherapy during the perinatal period with special reference to such derivatives of cephalosporin C as cefazolin, cephaloridine and cephalothin.
    Fukada M
    Jpn J Antibiot; 1973 Jun; 26(3):197-214. PubMed ID: 4542543
    [No Abstract]   [Full Text] [Related]  

  • 11. Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration.
    Nishida M; Matsubara T; Murakawa T; Mine Y; Yokota Y; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1970 Apr; 23(4):184-94. PubMed ID: 5423363
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and clinical use of cephalosporin antibiotics.
    Nightingale CH; Greene DS; Quintiliani R
    J Pharm Sci; 1975 Dec; 64(12):1899-926. PubMed ID: 1107514
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue cage experiments with beta-lactam antibiotics in rabbits.
    Carbon C; Chau NP; Contrepois A; Lamotte-Barrillon S
    Scand J Infect Dis Suppl; 1978; (14):127-34. PubMed ID: 279966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of cephalothin, cephaloridine and cefazolin to human serum proteins.
    Miyake Y; Ebata M
    J Antibiot (Tokyo); 1976 Jun; 29(6):667. PubMed ID: 950323
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of cephalosporin antibiotics.
    Brogard JM; Comte F; Pinget M
    Antibiot Chemother (1971); 1978; 25():123-62. PubMed ID: 352251
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies with cefuroxime and cefoxitin.
    Geddes AM; McGhie D; Ball AP; Gould I
    Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary tract excretion of cefazolin, cephalothin, and cephaloridine in the presence of biliary tract disease.
    Ratzan KR; Ruiz C; Irvin GL
    Antimicrob Agents Chemother; 1974 Oct; 6(4):426-31. PubMed ID: 4157339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of diffusion chambers as models for the description of drug disposition.
    Ganzinger U; Schiel H; Georgopoulos A; Gumhold G
    J Antimicrob Chemother; 1986 Jul; 18(1):93-102. PubMed ID: 3759726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.